乌鸡白凤丸巩固治疗复发性外阴阴道念珠菌病的临床研究

中国真菌学杂志　 2013, Vol. 8 　Issue (5): 285-288,293.

乌鸡白凤丸巩固治疗复发性外阴阴道念珠菌病的临床研究

葛覃¹, 刘延², 滕宗荣², 沈健²

1. 上海交通大学医学院附属瑞金医院药剂科, 上海 200025;
2. 上海交通大学医学院附属瑞金医院妇产科, 上海 200025

收稿日期:2013-07-15 出版日期:2013-10-28 发布日期:2013-10-28
通讯作者: 沈健,E-mail:ivfshenjian@163.com E-mail:ivfshenjian@163.com
作者简介:葛覃,男 (汉族),学士,主管药师.E-mail:getan888@hotmail.com

Maintenance White Phoenix bolus therapy for recurrent vulvovaginal Candidiasis

GE Tan¹, LIU Yan², TENG Zong-rong², SHEN Jian²

1. Department of Pharmacy, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025;
2. Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025

Received:2013-07-15 Online:2013-10-28 Published:2013-10-28

摘要/Abstract

摘要： 目的应用乌鸡白凤丸巩固治疗复发性外阴阴道念珠菌病 (Recurrent Vulvovaginal Candidiasis,RVVC),通过观察其疗效及安全性,探讨其有无降低RVVC复发率的作用。方法 486名处于VVC急性发作且以往有RVVC史的非孕育龄妇女,急性期阴道给予克霉唑栓强化治疗。达到临床及真菌治愈标准后,随机分为3组采取不同方案进行巩固治疗或临床观察。A组:每月月经净后3~7 d,继续单次阴道给予克霉唑栓500 mg,为期3个月;B组:每月月经净后口服乌鸡白凤丸每次1丸,1次/d,3周为1个疗程,连用3个月。对照组:仅作随访观察。各组在巩固治疗期间及巩固治疗结束后6个月内进行随访,观察疗效及不良反应发生情况。结果巩固治疗期间,A组和B组分别累计有17人 (10.12%)和23人 (13.61%)出现复发,显著低于对照组 (P<0.001)。巩固治疗结束后,随访第3个月A组和B组分别累计有31人 (21.83%)和37人 (26.62%)出现复发;随访第6个月A组和B组分别累计有73人 (51.41%)和79人 (56.83%)出现复发,均显著低于对照组 (P<0.001),A、B组间各阶段复发率无显著差异 (P>0.05),不良反应轻微。结论 RVVC近期治愈后采用乌鸡白凤丸巩固治疗,能够抑制念珠菌生长,增强免疫功能,控制阴道局部炎症反应,有效预防复发,效果满意且相对安全,值得临床应用与推广。

关键词: 复发性外阴阴道念珠菌病 (RVVC), 巩固治疗, 乌鸡白凤丸, 克霉唑

Abstract: Objective White Phoenix bolus was used to explore and investigate a new optional management of recurrent vulvovaginal candidiasis (RVVC).Methods After inducing clinical remission and microbiological cure with clotrimazole suppositories given in two 500 mg doses at 72 hour intervals, 486 women with recurrent vulvovaginal candidiasis were randomly divided into three groups. After menstruation, group A were treated with intravaginal clotrimazole (500 mg) monthly for three months. Group B were treated with White Phoenix bolus, one pill daily for three monthly except menstrual period. The others were designated as Control Group. All women were followed by six months of observation without therapy. The outcome measure was the proportion of women in clinical remission at the end of the maintenance treatment and six-month follow-up period.Result The proportions of women who suffered with recurrence at the end of the treatment and 3,6 months follow-up in White Phoenix bolus group were 13.61%, 26.62% and 56.83%, similar to those in clotrimazole group (10.12%, 21.83% and 51.41%,P>0.05), and significantly decreased as compared with 40.27%, 57.30% and 68.54%, respectively, in the control group (P<0.001). The adverse effect was slight and could rarely be seen.Conclusion Long-term treatment with White Phoenix bolus can inhibit the growth of candida, boost up the immunity of host, control the local inflammation and reduce the rate of recurrence of symptomatic vulvovaginal candidiasis. The study may represent a safe and effective alternative to RVVC.

Key words: recurrent vulvovaginal candidiasis (RVVC), maintenance therapy, White Phoenix bolus, Clotrimazole

中图分类号:

R711.31

葛覃, 刘延, 滕宗荣, 沈健. 乌鸡白凤丸巩固治疗复发性外阴阴道念珠菌病的临床研究[J]. 中国真菌学杂志, 2013, 8(5): 285-288,293.

GE Tan, LIU Yan, TENG Zong-rong, SHEN Jian. Maintenance White Phoenix bolus therapy for recurrent vulvovaginal Candidiasis[J]. Chinese Journal of Mycology, 2013, 8(5): 285-288,293.

参考文献

[1] Sobel JD, Faro S, Force RW,et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations[J]. Am J Obstet Gynecol,1998,178(2):203-211.
[2] Spinillo A, Pizzoli G, Colonna L, et al. Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis[J]. Obstet Gynecol,1993,81 (5 ( Pt 1)):721-727.
[3] Foxman B, Marsh JV, Gillespie B, et al. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey[J]. J Womens Health,1998,7(9):1167-1174.
[4] 杨慧霞.外阴阴道念珠菌病诊治规范(草案)[J]. 中华妇产科杂志, 2004,39(6):430-431.
[5] Sobel JD, Wiesenfeld HC, Marten M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis[J]. N Engl J Med,2004, 351(9):876-883.
[6] 段涛.美国疾病预防与控制中心"外阴阴道假丝酵母菌病治疗指南"解读[J].中华妇产科杂志,2008,43(3):239-240.
[7] Bauters TG, Dhont MA, Temmerman MI, et al. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women[J]. Am J Obstet Gynecol,2002,187(3):569-574.
[8] Beigi RH, Meyn LA, Moore DM, et al. Vaginal yeast colonization in nonpregnant women: A longitudinal study[J]. Obstet Gynecol,2004,104(5 Pt 1):926-930.
[9] Harriott MM, Lilly EA, Rodriguez TE, et al. Candida albicans forms biofilms on the vaginal mucosa[J]. Microbiology,2010,156(Pt 12):3635-3644.
[10] Hasan F, Xess I, Wang X, et al. Biofilm formation in clinical Candida isolates and its association with virulence[J]. Microbes Infect,2009,11(8-9):753-761.
[11] Sivasubramanian G, Sobel JD. Refractory urinary tract and vulvovaginal infection caused by Candida krusei[J]. Int Urogynecol J Pelvic Floor Dysfunct,2009,20(11):1379-1381.
[12] Fidel PL Jr, Barousse M, Espinosa T, et al. An intravaginal live Candida challenge in humans leads to new hypothesis for the immunopathogenesis of vulvovaginal candidiasis[J]. Infect Immun,2004,72(5):2939-2946.
[13] Yano J, Lilly E, Barousse M, et al. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis[J]. Infect Immun,2010,78(12):5126-5137.
[14] Barousse MM, Steele C, Dunlap K, et al. Growth inhibition of Candida albicans by human vaginal epithelial cells[J]. J Infect Dis,2001,184(11):1489-1493.
[15] Steele C, Fidel PL Jr. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans[J]. Infect Immun,2002,70(2):577-583.
[16] Pivarcsi A, Nagy I, Koreck A, et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells[J]. Microbes Infect,2005,7(9-10):1117-1127.
[17] 张风梧. 乌鸡白凤丸治疗慢性前列腺炎100例[J].安徽中医学院学报,2002,21(3):23.
[18] 程春林. 头孢克洛、甲硝唑、乌鸡白凤丸综合治疗细菌性阴道病104例[J]. 中华医学实践杂志,2003,2(4):333-334.
[19] 寇丽妍. 外治法治疗孕妇霉菌性阴道炎80例[J]. 实用中医内科杂志,2003, 17(3).
[20] 宫毓静,安汝国,虞慧等. 164种中药乙醇提取物抗真菌作用研究[J].中草药,2002,33(1):42-47.
[21] 王理达,胡迎庆,屠鹏飞等. 13种生药提取物及化学成分的抗真菌活性筛选[J].中草药,2001,32(3):241-244.
[22] 赵民,周曾同. 白芍总苷和盐酸小蘖碱的抗口腔念珠菌活性研究[J]. 口腔医学,2007,27(1): 21-22.
[23] 王昊,杨凤琴,潘梅等. 10种中药对致病性浅部真菌的抑菌实验研究[J].中医杂志,1997,38(7):431-432.
[24] 聂紫雯,魏强华. 黄芪免疫调节机制及临床应用进展[J]. 中国中医药信息杂志,2009,8(16).
[25] 冯俊志,赵国平. 当归的免疫药理研究进展[J]. 福建中医药, 2003, 34(3):49-51.
[26] 杨错,邢立国,刘玉兰. 柴胡乳剂对小鼠免疫功能的影响[J]. 沈阳药科大学学报,2006,23(3):169-171.
[27] 杨立平,胡爱平. 乌鸡白凤丸的研究与应用概况[J]. 中国实验方剂学杂志,2001,7(2):62-64.